Physician profile
Louis Chu
NPI 1326288473
$10,744.67
in general payments reported to CMS, 2019-2025
7 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,370 · 2020: $1,748 · 2021: $1,103 · 2022: $991 · 2023: $247 · 2024: $1,467 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,900 · Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,900.00 |
| Food and Beverage | $1,632.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,240.73 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $3,187.67 | 2019-2020 | |
| Medtronic, INC. | $2,923.58 | 2021-2025 | Penditure, Avalus, Corevalve Evolut R |
| Atricure, INC. | $718.94 | 2019-2024 | |
| Medtronic Vascular, INC. | $337.83 | 2019-2020 | |
| Abiomed | $296.04 | 2019-2024 | Impella |
| Boston Scientific Corporation | $39.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.